Stephen Doster
-
Grant bolsters VUIIS ‘deep tissue’ imaging research
Dec. 2, 2020, 11:18 AM by Bill Snyder Researchers in the Vanderbilt University Institute of Imaging Science (VUIIS) have received a $1 million grant from the Chan Zuckerberg Initiative to develop “deep tissue” imaging methods that can peer into the furthest corners of the body. Through the application… Read MoreDec. 2, 2020
-
Vanderbilt-Ancora partnership advances research for Charcot-Marie-Tooth disease
by Marissa Shapiro Nov. 17, 2020, 12:00 PM Ancora Innovation LLC, a Deerfield Management company that supports Vanderbilt University’s innovative life science research, will fund further research into therapeutics for Charcot-Marie-Tooth disease, an inherited condition that damages peripheral nerves. This is the third Vanderbilt project… Read MoreNov. 18, 2020
-
Vanderbilt researchers work to build a molecular Trojan horse to battle COVID-19
pair of Vanderbilt University researchers are focusing on proteins that may lead to an inside track on battling COVID-19. Envelope proteins—small membrane proteins—have an important yet unknown role in the development and virulence of multiple coronaviruses, including SARS-CoV-2. “We know this is an important protein because its removal impedes the… Read MoreNov. 18, 2020
-
Vanderbilt honors distinguished faculty with endowed chairs
by Morgan Kroll Nov. 11, 2020, 11:24 AM (Vanderbilt University) Twenty-nine prominent faculty from across campus comprise Vanderbilt University’s latest endowed chair honorees. They include scholars working in diverse areas—from election analysis and lung cancer research to the nascent field of neurolaw, exploring the… Read MoreNov. 13, 2020
-
Vanderbilt contributes to the ‘Google Earth’ of the human body, starting with the kidney
by Marissa Shapiro Nov. 12, 2020, 9:00 AM Multimodal molecular imaging data collected from the human kidney by the BIOMIC team. Imaging mass spectrometry data was collected by Elizabeth Neumann, a postdoctoral fellow working with Drs. Spraggins and Caprioli, and multiplexed IF microscopy images… Read MoreNov. 12, 2020
-
New therapeutic target for lung cancer
Nov. 12, 2020, 9:00 AM by Sarah Glass Continuous activation of cell surface receptors increases signaling that can promote oncogenic transformation. One receptor, EphA2, has been identified as a driver of lung cancer, but its interacting partners are not well characterized. Reporting in Molecular Cancer Research, … Read MoreNov. 12, 2020
-
Ask an Expert: What effect has the pandemic had on the opioid crisis?
Erin Calipari, assistant professor of pharmacology and of psychiatry and behavioral sciences, discusses the COVID-19 pandemic’s impact on those struggling with opioid addiction. Read MoreNov. 11, 2020
-
Vanderbilt biologist uses rabies-like virus to illuminate how SARS-CoV-2 blocks immune response
by Marissa Shapiro Nov. 9, 2020, 8:00 AM Yi Ren, assistant professor of biochemistry Vanderbilt University researcher Yi Ren is part of an international team that has confirmed the mechanism by which SARS-CoV-2, the scientific name for the strain of coronavirus causing COVID-19, targets and… Read MoreNov. 11, 2020
-
Ren’s lab advances SARS-CoV-2 research and prioritizes safety during Research Ramp-up
Nov. 6, 2020, 8:00 AM By Jenna Somers and Jane Hirtle Yi Ren, assistant professor of biochemistry As a structural biologist, Yi Ren, assistant professor of biochemistry in the School of Medicine Basic Sciences, studies the structure of biological molecules at the atomic level to understand… Read MoreNov. 6, 2020
-
Spontaneous release of neurotransmitters in the brain identified as a culprit of developmental disorders in infants and children
by Marissa Shapiro Nov. 3, 2020, 12:00 PM Vanderbilt pharmacologists have reported the first evidence that aberrant spontaneous release of neurotransmitters in the brain can cause a range of severe intellectual and neurodevelopmental disorders in infants and children. Baris Alten (Baris Alten) Ege Kavalali… Read MoreNov. 5, 2020